2022. Pharmaceutical attention in the treatment of obesity involving analogues of Glucagon-like peptide 1 (GPL-1). Research, Society and Development. 11, 7 (May 2022), e41011730134. DOI:https://doi.org/10.33448/rsd-v11i7.30134.